Allspring Global Investments Holdings LLC Decreases Position in SPDR S&P Biotech ETF $XBI

Allspring Global Investments Holdings LLC cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 134,066 shares of the exchange traded fund’s stock after selling 7,535 shares during the period. Allspring Global Investments Holdings LLC’s holdings in SPDR S&P Biotech ETF were worth $11,118,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Fulcrum Capital LLC raised its position in SPDR S&P Biotech ETF by 6.0% during the second quarter. Fulcrum Capital LLC now owns 54,960 shares of the exchange traded fund’s stock valued at $4,558,000 after purchasing an additional 3,122 shares during the period. Robertson Stephens Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 36.4% during the second quarter. Robertson Stephens Wealth Management LLC now owns 4,721 shares of the exchange traded fund’s stock valued at $392,000 after purchasing an additional 1,261 shares during the period. IFP Advisors Inc raised its position in SPDR S&P Biotech ETF by 22.8% during the second quarter. IFP Advisors Inc now owns 3,909 shares of the exchange traded fund’s stock valued at $324,000 after purchasing an additional 727 shares during the period. Meitav Investment House Ltd. raised its position in SPDR S&P Biotech ETF by 2,199.6% during the second quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock valued at $33,229,000 after purchasing an additional 383,040 shares during the period. Finally, Viewpoint Capital Management LLC raised its position in SPDR S&P Biotech ETF by 42.9% during the second quarter. Viewpoint Capital Management LLC now owns 10,000 shares of the exchange traded fund’s stock valued at $829,000 after purchasing an additional 3,000 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $107.80 on Friday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $110.96. The stock’s 50 day simple moving average is $96.06 and its two-hundred day simple moving average is $86.64. The company has a market cap of $6.70 billion, a PE ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.